Membranous Nephropathy (MN) represents a large amount of Nephrotic Syndromes in the
adult population and its definitive diagnosis is currently carried out through biopsy. An …

Autoantibodies against the M-type phospholipase A 2 receptor (PLA 2 R) are specific
markers for primary membranous nephropathy (MN). Quantification of PLA 2 R …

Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …

Multiple autoantigens have been identified in membranous nephropathy (MN) by tissue-
based proteomics. However, antigenic targets of disease are unknown for over 10% of …

Background The pathogenesis of primary membranous nephropathy (MN) involves the
antibodies against antigens on the cell surface of podocytes, with the majority of M-type …

Background Membranous nephropathy (MN) is mainly classified into idiopathic MN (iMN)
and secondary MN in etiology. In recent years, a new kind of membranous nephropathy …

Membranous nephropathy (MN) is a rare, but severe autoimmune kidney disease and a
major cause of nephrotic syndrome in adults. Clinically defined by nephrotic syndrome …

Idiopathic membranous nephropathy (IMN), a common pathological type of nephrotic
syndrome, is one of the main causes of kidney failure. With an increasing prevalence, IMN …

Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …